newsfilter
← Latest News
Business Wire·

Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — Omeros Corporation (NASDAQ:OMER) today announced the successful completion of its initial study in nonhuman